Fig. 9From: Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approachTime dependent secondary structure content. (A) ELAVL2 protein. (B) ELAVL2 after interaction of ZINC03830554Back to article page